COVID-19 Records

Reading Room Production — page 354

of 496 pages

← p.353 p.355 → · this page in the original PDF · package

[ JJ erred in pointing you t ur domain and frankly, not a r NIH staff who d learn about litics around you have a ony sent me n detail to the [ should I reached out, ve mentioned oved to Richard thinks aying anything Ok, thanks. Will deflect. I was not asking to be involved in this stuff - it was just meant to be a casual conversation with one of our detailees... Rajesh On 11/18/10 9:14 PM, "Hudson, Kathy (NIH/OD) [E]" @nih.gov wrote: Thanks for asking. My knee jerk reaction is to support your misgivings. I > think it is a bad idea for a whole bunch of reasons. JJ erred in pointing you to the white house. Protocol dictates that we don't talk to the white house > without going through hhs. It would be okay to yak with one of our detailees but this has taken a turn. Plus, I suspect you know next to nothing about > biosecurity and BARDA. This is not really your domain and frankly, not a central issue to NCTS at the outset. It IS the domain of other NIH staff who > would probably be a little miffed about why you are suddenly in the middle of their "space." NIAID has programs in this arena and you should learn about > them but they ain't coming into to ncts at the get go and the politics around biosecurity is complex. > I would suggest to Richard that the meeting be "delayed" until you have a > better understanding of what Francis has in mind, yadda yadda. > > > -----Original Message----- From: Ranganathan, Rajesh (NIH/OD) [C] > Sent: Thursday, November 18, 2010 6:51 PM To: Hudson, Kathy (NIH/OD) [E] > Cc: Tabak, Lawrence (NIH/OD) [E] Subject: FW: Discussion about Cures Acceleration Network and the President's > Medical Countermeasures Initiative (MCMI) > Kathy: > Some background for you (I was able to tell Larry in person)..Tony sent me to JJ McGowan, who thought that Richard Hatchett, currently on detail to the > White House is someone I should talk to because he might have the skill set to help with NCTS. I checked in with Larry and we agreed that I should > certainly meet such people and hear them out. So, when Richard reached out, I agreed to go down to the EEOB to meet him. He appears to have mentioned > that he is meeting me to Ms. Heidi Avery (Deputy Homeland Security Adviser to the President), who now wants to join in and the meeting got moved to > Monday to accommodate her schedule. Please see below for what Richard thinks Ms. Avery wants to know. > Two issues: a) there is not much I can say about CAN or anything else re: > NCTS on Monday, and b) as a contractor, I should not be reprenseting the NIH externally. Larry has arranged from Robin from DPCPSI to go with me to > ensure that the NIH is represented by an employee. > But I am wondering if this meeting with Ms. Avery should even happen - feels too early in the process Please advise on the ramifications of > cancelling/postponing on her vs. taking the meeting and not saying anything

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/reading_room/354

Records on this page

RecordDateTypePages
FW: Discussion about Cures Acceleration Network and the President's 2010-11-18 email 354–355
Re: Discussion about Cures Acceleration Network and the President's Medical Countermeasures Initiative (MCMI) [ JJ erred in pointing you t ur domain and frankly, not a r NIH staff who d learn about litics around you have a ony sent me n detail to the [ should I reached out, ve mentioned oved to Richard thinks aying anything Ok, thanks. Will deflect. I was not asking to be involved in this stuff - it was just meant to be a casual conversation with one of our detailees... Rajesh On 11/18/10 9:14 PM, "Hudson, Kathy (NIH/OD) [E]" @nih.gov wrote: Thanks for asking. My knee jerk reaction is to support your misgivings. I > think it is a bad idea for a whole bunch of reasons. JJ erred in pointing you to the white house. Protocol dictates that we don't talk to the white house > without going through hhs. It would be okay to yak with one of our detailees but this has taken a turn. Plus, I suspect you know next to nothing about > biosecurity and BARDA. This is not really your domain and frankly, not a central issue to NCTS at the outset. It IS the domain of other NIH staff who > would probably be a little miffed about why you are suddenly in the middle of their "space." NIAID has programs in this arena and you should learn about > them but they ain't coming into to ncts at the get go and the politics around biosecurity is complex. > I would suggest to Richard that the meeting be "delayed" until you have a > better understanding of what Francis has in mind, yadda yadda. > > > -----Original Message----- 2010-11-18 email 353–354